Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic

Leukemia. 2022 Dec;36(12):2908-2911. doi: 10.1038/s41375-022-01730-x. Epub 2022 Oct 26.

Arndt Borkhardt^{1

2}, Joachim Schüz³, Claudia Trübenbach⁴, Maike Wellbrock⁴, Claudia Spix⁴, Friederike Erdmann^{3

4

5}

¹ Department of Paediatric Oncology, Haematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine-University, Moorenstraße 5, 40225, Düsseldorf, Germany. Arndt.Borkhardt@med.uni-duesseldorf.de.
² German Cancer Consortium (DKTK), partnering site Essen/ Düsseldorf, Düsseldorf, Germany. Arndt.Borkhardt@med.uni-duesseldorf.de.
³ Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer, World Health Organization (IARC/WHO), 150 cours Albert Thomas, 69372, Lyon, France.
⁴ Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Obere Zahlbacher Straße 69, 55131, Mainz, Germany.
⁵ Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Achterstraße 30, 28359, Bremen, Germany.

No abstract available

MeSH terms